Approval · Notice of Compliance 24008 · 2020
OTEZLA: Notice of Compliance 24008
Issued August 10, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24008
- Date
- August 10, 2020
- Company
- Amgen Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OTEZLA | Not yet assigned | — |
Medicinal ingredients
- APREMILAST 10 MG per TAB
- APREMILAST 20 MG per TAB
- APREMILAST 30 MG per TAB